In hepatocellular carcinoma and malignant melanoma IGFBP7 was even suggested as therapeutic agent as it inhibited tumor cell viability and promoted apoptosis in vivo and in vitro [12–14]. The gene discussed is IGFBP7; the disease is hepatocellular carcinoma.